Purdue Canada

Purdue Pharma (Canada) is a research-based pharmaceutical company headquartered in Pickering, Ontario, specializing in pain management, central nervous system disorders, and supportive care. As an independent associated entity within the global Purdue/Mundipharma network, the company is widely recognized for its portfolio of analgesic medications, including OxyNEO and Hydromorph Contin. Beyond pain, Purdue Canada markets Biphentin for the treatment of ADHD and maintains a presence in the consumer health market with brands like Senokot and Betadine. The company operates its own manufacturing and research facilities in Canada, focusing on advanced drug delivery systems and controlled-release technologies. In recent years, Purdue Canada has been significantly involved in legal restructuring and settlements related to the opioid crisis, mirroring challenges faced by its international affiliates. Despite these challenges, it remains an active player in the Canadian healthcare sector, providing a range of prescription and over-the-counter therapeutic solutions.